Resource Center
Browse industry research articles, publications, and other important resources.
-
browse
By Topic
By Disease Area
-
Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project
Posted May 21, 2018 by Elizabeth Clearfield, MHS ,Donna Messner, PhD ,Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Iorio A, Skinner MW, Clearfield E, Messner D, Pierce GF, Witkop M, Tunis S; for the coreHEM panel. Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project. Haemophilia. 2018;00:1 '6. https://doi.org/10.1111/hae.13504
-
coreHEM: Developing Comparative Effectiveness Outcomes for Gene Therapy in Hemophilia
Posted May 21, 2018 by Elizabeth Clearfield, MHS ,Donna Messner, PhD ,Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
coreHEM has produced the first set of guidelines recommending a specific, minimum set of outcomes to include in hemophilia gene therapy clinical trials. This core set will ensure that patient perspectives on critical outcomes are included in pivotal trials, allow fair comparisons between alternative treatments, and allow more accurate assessments of the value of these therapies. The coreHEM project was jointly led by the Green Park Collaborative (GPC), the National Hemophilia Foundation (NHF), and McMaster University.